Alessandro Ciarcia: Connecting Expertise and Innovation to Transform the Future of TTP Management at ISTH 2026
Alessandro Ciarcia, Marketing Director at Sanofi, shared a post on LinkedIn:
“Excited to be at ISTH 2026, where the global thrombosis and hemostasis community comes together to share knowledge, challenge ideas, and drive progress for patients.
One of the greatest values of this meeting is the opportunity to engage in meaningful conversations with leading experts, clinicians, researchers, and industry partners who are advancing our understanding of thrombotic thrombocytopenic purpura (TTP)—a rare, life-threatening disease where continued collaboration, innovation, and scientific exchange can have a meaningful impact on patient outcomes.
Looking forward to learning from the latest science, exchanging perspectives, and building connections that help move the field forward.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Jul 15, 2026, 05:02Louise St. Germain Bannon: Scientific Collaboration at ISTH 2026
-
Jul 15, 2026, 04:49Nathan Connell: Professional Connections That Stand the Test of Time at ISTH 2026
-
Jul 15, 2026, 04:41Heghine Khachatryan: Efgartigimod Shows Promising Results in iTTP
-
Jul 15, 2026, 04:30Sandeep Jagtap: Presenting the Research Behind Pediatric Fondaparinux at ISTH 2026
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP